Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
Trial Parameters
Brief Summary
The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycemia and hyperglycemia episodes without negatively affecting patients' satisfaction, providers and your nurses satisfaction with how glucose is monitored and treated in the hospital.
Eligibility Criteria
Inclusion Criteria: 1. Patients with ages above 18 years old at the time of informed consent. 2. Male or female 3. Admitted to non-ICU setting in brick-and-mortar medical and surgical ward or admitted to Advanced Care at Home Program. 4. Admitted under observation or inpatient status. 5. Expected to remain in the hospital for more than 48 hours. 6. Patients that are using a transcutaneous or implantable real time CGM as outpatient and are bringing it to the hospital. 7. Patients with diagnosis of diabetes mellitus or hyperglycemia requiring treatment with SQ insulin in the hospital either with multiple daily injections or subcutaneous infusion of insulin via insulin pump. Exclusion Criteria: 1. Participants unable to provide informed medical consent. 2. Participants admitted to Intensive Care Units (ICU). Enrollment is possible after transferring out of the ICU. 3. Actively being treated for DKA (diabetes ketoacidosis) or HHS (hyperosmolar hyperglycemic state) 4. Patients with a diagno